The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Chromoendoscopy-Targeted Biopsies Are Superior to Standard Colonoscopic Surveillance for Detecting Dysplasia in Inflammatory Bowel Disease Patients: A Prospective Endoscopic Trial
Abstract
OBJECTIVES: Patients with extensive, longstanding chronic ulcerative or Crohn's colitis face greater risks of developing colorectal cancer. Current standard surveillance relies on detecting dysplasia using random sampling at colonoscopy but may fail to detect dysplasia in many patients. Dye spraying techniques have been reported to aid in detecting otherwise subtle mucosal abnormalities in the setting of colitis. We prospectively compared dye-spray technique using methylene blue to standard colonoscopic surveillance in detecting dysplasia. METHODS: One hundred fifteen patients were referred to the Chromoendoscopy Study Group and prospectively screened for the study. One hundred two (64 M, 38 F) (79 UC 23 CC) patients meeting the inclusion criteria were enrolled. Following a standard bowel preparation, each patient was examined using standard office endoscopic equipment by three methods: (a) standard surveillance colonoscopy with four random biopsies every 10 cm (for a total of at least 32 samples); (b) a targeted biopsy protocol; and finally (c) methylene blue (0.01%) dye spray was segmentally applied throughout the colon and any pit-pattern abnormality or lesion rendered visible by the dye spray was targeted and biopsied. Each patient had a single examination, which included two passes of the colonoscope. Specimens were reviewed in a blinded fashion by a single gastrointestinal pathologist. The three methods were then compared with each patient serving as his or her own control. RESULTS: Targeted biopsies with dye spray revealed significantly more dysplasia (16 patients with low grade and 1 patient with high grade) than random biopsies (3 patients with low-grade dysplasia) (P= 0.001) and more than targeted nondye spray (8 patients with low-grade and 1 patient with high-grade dysplasia) (P= 0.057). Targeted biopsies with and without dye spray detected dysplasia in 20 patients compared with 3 using Method (a) (P= 0.0002, two-tailed exact McNemar's Test). There were no adverse events. CONCLUSIONS: Colonoscopic surveillance of chronic colitis patients using methylene blue dye-spray targeted biopsies results in improved dysplasia yield compared to conventional random and targeted biopsy methods. Accordingly, this technique warrants incorporation into clinical practice in this setting and consideration as a standard of care for these patients. The value of multiple random biopsies as a surveillance technique should be revisited.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,289
Ulcerative Colitis and Colorectal Cancer: A Population-Based Study
Ekbom, A., Helmick, C., Zack, M., & Adami, H.-O. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,777
Kiesslich, R., Fritsch, J., Holtmann, M., Koehler, H. H., Stolte, M., Kanzler, S., Nafe, B., Jung, M., Galle, P. R., & Neurath, M. F. (2003) · Gastroenterology · doi:10.1053/gast.2003.50146 · Cited by 861
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?
Shanahan, F., Weinstein, W. M., & Bernstein, C. N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90813-3 · Cited by 584
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis
Rubin, C. E., Haggitt, R. C., Burmer, G. C., Brentnall, T. A., Stevens, A. C., Levine, D. S., Dean, P. J., Kimmey, M., Perera, D. R., & Rabinovitch, P. S. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91185-7 · Cited by 568
Consensus Conference: Colorectal Cancer Screening and Surveillance in Inflammatory Bowel Disease
Itzkowitz, S. H., & Present, D. H. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160811.76729.d5 · Cited by 564
Self-citationPancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis
Rutter, M. D., Saunders, B. P., Schofield, G., Forbes, A., Price, A. B., & Talbot, I. C. (2004) · Gut · doi:10.1136/gut.2003.016386 · Cited by 520
Ulcerative colitis and colorectal cancer
Ekbom, A. (1991) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(91)90009-i · Cited by 419
Rubin, P. H., Friedman, S., Harpaz, N., Goldstein, E., Weiser, J., Schiller, J., Waye, J. D., & Present, D. H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70279-9 · Cited by 355
Self-citationMost dysplasia in ulcerative colitis is visible at colonoscopy
Rutter, M. D., Saunders, B. P., Wilkinson, K. H., Kamm, M. A., Williams, C. B., & Forbes, A. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)01710-9 · Cited by 315
Cited by
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
European evidence based consensus for endoscopy in inflammatory bowel disease
Annese, V., Daperno, M., Rutter, M. D., Amiot, A., Bossuyt, P., East, J., Ferrante, M., Götz, M., Katsanos, K. H., Kießlich, R., et al. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.09.016 · Cited by 815
Laine, L., Kaltenbach, T., Barkun, A., McQuaid, K. R., Subramanian, V., Soetikno, R., East, J. E., Farraye, F. A., Feagan, B., Ioannidis, J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.031 · Cited by 776
Self-citationEuropean consensus on the histopathology of inflammatory bowel disease
Magro, F., Langner, C., Driessen, A., Ensari, A., Geboes, K., Mantzaris, G. J., Villanacci, V., Becheanu, G., Nunes, P. B., Cathomas, G., et al. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.06.001 · Cited by 731
Metadata
- Authors
- Marion, J. F., Waye, J. D., Present, D. H., Israel, Y., Bodian, C., Harpaz, N., Chapman, M., Itzkowitz, S., Steinlauf, A. F., Abreu, M. T., Ullman, T. A., Aisenberg, J., Mayer, L., & the Chromoendoscopy Study Group at Mount Sinai School of Medicine
- Venue
- The American Journal of Gastroenterology
- Published
- 2008-09
- Volume
- 103
- Issue
- 9
- Pages
- 2342-2349
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W2043004569
- Cited by
- 287
- References
- 17
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chromoendoscopy-Targeted Biopsies Are Superior to Standard Colonoscopic Surveillance for Detecting Dysplasia in Inflammatory Bowel Disease Patients: A Prospective Endoscopic Trial. https://app.cochat.ai/papers/10.1111/j.1572-0241.2008.01934.x
- The paper
- Marion, J. F., Waye, J. D., Present, D. H., Israel, Y., Bodian, C., Harpaz, N., Chapman, M., Itzkowitz, S., Steinlauf, A. F., Abreu, M. T., Ullman, T. A., Aisenberg, J., Mayer, L., & the Chromoendoscopy Study Group at Mount Sinai School of Medicine. (2008). Chromoendoscopy-Targeted Biopsies Are Superior to Standard Colonoscopic Surveillance for Detecting Dysplasia in Inflammatory Bowel Disease Patients: A Prospective Endoscopic Trial. The American Journal of Gastroenterology. https://doi.org/10.1111/j.1572-0241.2008.01934.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.